Assembly Biosciences Stock Performance
| ASMB Stock | USD 13.33 0.41 3.17% |
On a scale of 0 to 100, Assembly Biosciences holds a performance score of 10. The firm shows a Beta (market volatility) of 1.37, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Assembly Biosciences will likely underperform. Please check Assembly Biosciences' sortino ratio, semi variance, rate of daily change, as well as the relationship between the value at risk and kurtosis , to make a quick decision on whether Assembly Biosciences' price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Assembly Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting primary indicators, Assembly Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (12.23) | Five Day Return (13.69) | Year To Date Return 29.46 | Ten Year Return (80.94) | All Time Return (96.58) |
Last Split Factor 1:12 | Last Split Date 2024-02-12 |
1 | Wisconsin Supreme Court refuses to clarify district boundaries for potential recall election | 04/03/2024 |
2 | California congressional primary race ends in a tie, three candidates head to general election | 04/05/2024 |
3 | California court affirms Kevin McCarthy proteges dual candidacies on state ballot | 04/09/2024 |
4 | New York budget sees another delay over housing proposal negotiations | 04/11/2024 |
5 | Critics furious over Hochul, Heastie plan to crack down on NYs 8 billion home care Medicaid program Recipe for corruption | 04/12/2024 |
6 | Hochul announces budget outline as lawmakers continue to hash out details | 04/15/2024 |
7 | New Yorkers get next to nothing for their high state taxes Albany budget deal wont change that | 04/16/2024 |
| Begin Period Cash Flow | 52.4 M |
Assembly |
Assembly Biosciences Relative Risk vs. Return Landscape
If you would invest 1,031 in Assembly Biosciences on January 19, 2024 and sell it today you would earn a total of 302.00 from holding Assembly Biosciences or generate 29.29% return on investment over 90 days. Assembly Biosciences is currently generating 0.4702% in daily expected returns and assumes 3.5204% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Assembly, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Assembly Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assembly Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Assembly Biosciences, and traders can use it to determine the average amount a Assembly Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1336
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ASMB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.52 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.47 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Assembly Biosciences is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Assembly Biosciences by adding it to a well-diversified portfolio.
Assembly Biosciences Fundamentals Growth
Assembly Stock prices reflect investors' perceptions of the future prospects and financial health of Assembly Biosciences, and Assembly Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Assembly Stock performance.
| Return On Equity | -0.99 | ||||
| Return On Asset | -0.34 | ||||
| Operating Margin | (1.75) % | ||||
| Current Valuation | (48.3 M) | ||||
| Shares Outstanding | 5.48 M | ||||
| Price To Earning | (10.58) X | ||||
| Price To Book | 1.95 X | ||||
| Price To Sales | 11.21 X | ||||
| Revenue | 7.16 M | ||||
| Gross Profit | (63.9 M) | ||||
| EBITDA | (64.2 M) | ||||
| Net Income | (61.23 M) | ||||
| Cash And Equivalents | 116.69 M | ||||
| Cash Per Share | 2.41 X | ||||
| Total Debt | 2.34 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 8.31 X | ||||
| Book Value Per Share | 7.50 X | ||||
| Cash Flow From Operations | 22.74 M | ||||
| Earnings Per Share | (13.38) X | ||||
| Market Capitalization | 79.61 M | ||||
| Total Asset | 137.47 M | ||||
| Retained Earnings | (785.75 M) | ||||
| Working Capital | 94.56 M | ||||
| Current Asset | 68.37 M | ||||
| Current Liabilities | 3.4 M | ||||
About Assembly Biosciences Performance
To evaluate Assembly Biosciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Assembly Biosciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Assembly Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Assembly Biosciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Assembly's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.0007 | 0.0008 | |
| Return On Tangible Assets | (0.45) | (0.47) | |
| Return On Capital Employed | (0.66) | (0.69) | |
| Return On Assets | (0.45) | (0.47) | |
| Return On Equity | (1.49) | (1.42) |
Things to note about Assembly Biosciences performance evaluation
Checking the ongoing alerts about Assembly Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Assembly Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Assembly Biosciences had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (61.23 M) with loss before overhead, payroll, taxes, and interest of (63.9 M). | |
| Assembly Biosciences has a poor financial position based on the latest SEC disclosures | |
| About 33.0% of the company shares are held by company insiders | |
| Latest headline from nypost.com: New Yorkers get next to nothing for their high state taxes Albany budget deal wont change that |
- Analyzing Assembly Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Assembly Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Assembly Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Assembly Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Assembly Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Assembly Biosciences' stock. These opinions can provide insight into Assembly Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Assembly Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.38) | Revenue Per Share 1.565 | Quarterly Revenue Growth (1.00) | Return On Assets (0.34) | Return On Equity (0.99) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.